The Burden of Age-Related Macular Degeneration

Author： Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.4, 2006-01, pp. : 319-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study

By Cruess Alan F.

PharmacoEconomics, Vol. 26, Iss. 1, 2008-01 ,pp. : 57-73

Adis International

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration: Results of a Cohort Study in Two French Referral Centres

By Bonastre J.

PharmacoEconomics, Vol. 21, Iss. 3, 2003-01 ,pp. : 181-190

Adis International

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite

Prospective therapeutics for age-related macular degeneration

By Chiesa R.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 527-541

Informa Healthcare

Access to resources Recommend Favorite